Novo Holdings advances antimicrobial resistance strategy with acquisition of Paratek Pharmaceuticals PR Newswire COPENHAGEN, Denmark, Sept. 21, 2023 Paratek's successful commercialization platform to advance novel therapies developed organically and through acquisitions Paratek adds 'final-mile' capabilities to AMR efforts COPENHAGEN, Denmark , Sept. 21, 2023 /PRNewswire/ -- With the closing of the acquisition of Paratek Pharmaceuticals, Inc. ("Paratek"), a commercial-stage biopharmaceutical...